Aarti Pharmalabs fundamental analysis
AARTIPHARM
736.8
12.85 (-1.71%)Last updated on 1 Feb, 2026 | 15:43 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Aarti Pharmalabs Fundamentals
P/E Ratio
28.45
P/B Ratio
3.33
Div. Yield
0.66
Sector P/E
65.25
Sector P/B
1.2
Sec. Div. Yield
0.58
Aarti Pharmalabs Fundamentals is currently trading with a P/E Ratio of 28.45, compared to the sector average of 65.25. Its P/B Ratio stands at 3.33, while the sector’s is 1.2. In terms of returns, the stock offers a Dividend Yield of 0.66%, which is than the sector’s 0.58%.
Aarti Pharmalabs Score Card
Price
Expensive
Growth
Good
Quality
Good
Management
Good
On its scorecard, Aarti Pharmalabs reflects: Price – Expensive, Growth – Good, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
